Skip to main content
New Website! ¡Nuevo sitio web!

ALERT: We have made the Texas Children’s Health Plan website even easier to use! Click here to learn more.

ALERTA: ¡Ahora el sitio web de Texas Children’s Health Plan es aún más sencillo de usar! Haz clic aquí para más información.

Enfamil shortage updates Escasez de Enfamil Reguline

ALERT: Shortage of Enfamil products until August 31, 2024. Learn more.

ALERTA: Escasez de productos de Enfamil hasta el 31 de agosto de 2024. Más información.

Change Healthcare Incident Change Healthcare incidente

Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines Removed From Formulary on April 21, 2023

Date: May 8, 2023
 
Attention: All Providers

Effective Date: April 21, 2023

Call to action: Texas Children Health Plan (TCHP) would like to inform providers that effective April 21, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. This is to simplify the vaccination schedule for most individual vaccines, and monovalent are no longer authorized for use in the United States.

This announcement includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals six months and older, including for an additional dose or doses for specific populations.

How this impacts providers: HHSC removed the following monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines on April 21, 2023, due to the recent FDA announcement.

NDCLabel Name
59267100001Pfizer covid-19 vaccine-purple
59267100002Pfizer covid-19 vaccine-purple
59267100003Pfizer covid-19 vaccine-purple
80777027310Moderna covid (12y up)vac(eua)
80777027315Moderna covid (12y up)vac(eua)
80777027398Moderna covid (12y up)vac(eua)
80777027399Moderna covid (12y up)vac(eua)
80777027705Moderna covid(6-11y) vacc(eua)
80777027799Moderna covid(6-11y) vacc(eua)
80777027905Moderna covid(6m-5y) vacc(eua)
80777027999Moderna covid(6m-5y) vacc(eua)

Next steps for providers:

Providers should review the updated vaccination recommendations as it applies to members who:

  • originally received either of the monovalent Moderna or Pfizer-BioNTech COVID-19 vaccine
  • received any combination of monovalent and bivalent COVID-19 vaccines
  • are unvaccinated against COVID-19

Providers are encouraged to share this communication with their staff and to educate patients, our members.

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines

If you have any questions, please email Provider Network Management at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.